{"id":"W1972475443","doi":"10.1158/1535-7163.targ-11-c17","title":"Abstract C17: A phase I study of the combination of RO4929097 (RO) and cediranib (Cd) in patients with advanced solid tumors (PJC-004/NCI 8503).","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Pharmacology; Pharmacokinetics; Notch signaling pathway; Internal medicine; Gastroenterology; Toxicity; Response Evaluation Criteria in Solid Tumors; Maximum tolerated dose; Adverse effect; Oncology; Phases of clinical research; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001125614,0.001686015,0.002069687,0.0006325452,0.000519194,0.001134195,0.001247698,0.001434081,0.005670212],"category_scores_gemma":[0.0006486507,0.0006302737,0.0012781,0.0005176414,0.0008673288,0.000744634,0.0003814943,0.003411062,0.001994586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001123823,"about_ca_system_score_gemma":0.002044497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001706568,"about_ca_topic_score_gemma":0.003277696,"domain_scores_codex":[0.9996365,0.0001313412,0.00002340358,0.00007255564,0.00004922877,0.00008698651],"domain_scores_gemma":[0.9992674,0.00008403286,0.00009021947,0.00005480171,0.00004056679,0.0004629563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.532716,0.1335398,0.01160316,0.002030652,0.002506739,0.001394509,0.0005475593,0.004950132,0.1119829,0.001004256,0.01485107,0.1828732],"study_design_scores_gemma":[0.4424566,0.5296966,0.01316169,0.00006125186,0.0004294543,0.0009325291,0.00007290764,0.001342983,0.005410611,0.0001962737,0.006192996,0.00004612655],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849077,0.003350391,0.0008672908,0.0005741492,0.0001777943,0.004002586,0.002055653,0.0001866477,0.003877773],"genre_scores_gemma":[0.9796736,0.002482155,0.002979188,0.001303336,0.0001964328,0.003607344,0.004715368,0.00007612979,0.004966427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005670212,"threshold_uncertainty_score":0.01896876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01837690210788333,"score_gpt":0.2799707175247648,"score_spread":0.2615938154168814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}